Status:
COMPLETED
Effects of Kinesiotaping Technique on Lung Function & Functional Capacity of Chronic Obstructive Lung Disease Patients
Lead Sponsor:
Riphah International University
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
This study is designed to determine the effects of diaphragmatic kinesiotaping (KT) facilitation technique on pulmonary function, functional capacity and forward head posture of chronic obstructive lu...
Detailed Description
The Global Initiative for Chronic Obstructive Lung Disease 2019 report defines Chronic Obstructive Pulmonary Disorders (COPD) as a "common, preventable and treatable disease that is characterized by p...
Eligibility Criteria
Inclusion
- Diagnosed patients of COPD falling in stage I-III according to The Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.
- GOLD 1 -mild: Forced Expiratory Volume in 1 sec (FEV1) ≥80%, GOLD 2 - moderate: 50% ≤ FEV1 \<80% predicted and GOLD 3 - severe: 30% ≤ FEV1 \<50% predicted
- Age between 40-70 years.
- Both genders
- Volunteering to participate in study
Exclusion
- COPD exacerbation within last 4 weeks
- Allergic reaction to the taping material,
- Patients with recent chest wall trauma, surgery, deformity having scar, lesion, or incision in area of KT application.
- Uncontrolled arterial hypertension and diabetes mellitus.
- Patients with neurological, musculoskeletal, cardiac, pulmonary disease with physical impairment and history of psychiatric illness
Key Trial Info
Start Date :
September 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05258175
Start Date
September 15 2022
End Date
December 28 2022
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pak Medical Center Hospital
Peshawar, Khyber Pukhtunkhwa, Pakistan, 25000